Bacterial meningitis is a potentially life-threatening infection of the lining around the brain and spinal column. The disease affects as many as 3,000 Americans annually causing death or serious complications including amputations and brain seizures in those who survive. Who should receive the vaccine? There are two vaccines(Menactra and Menomune) available in the United States. Both vaccines can prevent four types of meningococcal disease, including two of the three most common types in the U.S. Meningococcal vaccines cannot prevent all types of the disease but do protect many people who might become sick if they didn't get the vaccine Menactra is licensed for individuals who are 11 thru 55 years of age. Menactra is recommended for all children 11 and 12 years of age, 15 and college freshmen living in dorms. Also, anyone traveling to a part of the world where meningitis disease is common; anyone who has a damaged spleen or whose spleen has been remove; or, anyone who has a an immune system disorder. Menomune should be used for adults over age 55 who are traveling to a part of the world where meningitis disease is common; anyone who has a damaged spleen or whose spleen has been removed; or anyone who has a an immune system disorder.
Resources American College Health Association Centers for Disease Control and Prevention (CDC) Meningitis Research Foundation Meningitis Foundation of America National Meningitis Foundation
Meningitis FAQ True life and death stories